CMS starts freezing regs
Executive Summary
A Federal Register notice announcing a 60-day extension of the effective date and comment period for a final rule on Medicaid premiums and cost sharing, originally published Nov. 25, will be the first freeze of a CMS pending rule after President Obama's Jan. 20 memo requesting such government-wide action on all pending regulations. The notice was put on display in the Office of the Federal Register Jan. 23. The freeze memo applies to any federal regulations that did not take effect before Obama took office on Jan. 20. Therefore, the rule on Medicare Part D protected classes is not expected to be affected by the freeze because it went into effect Jan. 16 (1"The Pink Sheet," Jan. 19, 2009, p. 14)
You may also be interested in...
CMS Opens Way To Add, Or Subtract, Protected Classes In Part D Formularies
CMS is creating a multi-step process that will give outside experts and the public a role in adding or subtracting "protected" drug classes in Medicare Part D, as well as making exceptions to the rule that all drugs must be covered in a protected class
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.
Ratio Therapeutics On BMS Investment, Radiopharma R&D Trends, AI Use
The CEO and CSO of radiopharmaceutical company Ratio Therapeutics, which now has Bristol Myers Squibb as an investor, talk about Ratio’s R&D platforms, use of AI, an independent FAP-targeted asset and trends in radiopharma research such as combining other modalities like ADCs, in this podcast interview with Scrip